188 related articles for article (PubMed ID: 28501939)
1. Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma.
Gilabert-Oriol R; Furness SGB; Stringer BW; Weng A; Fuchs H; Day BW; Kourakis A; Boyd AW; Hare DL; Thakur M; Johns TG; Wookey PJ
Cancer Immunol Immunother; 2017 Sep; 66(9):1217-1228. PubMed ID: 28501939
[TBL] [Abstract][Full Text] [Related]
2. Strategic Development of an Immunotoxin for the Treatment of Glioblastoma and Other Tumours Expressing the Calcitonin Receptor.
Gupta P; Hare DL; Wookey PJ
Cells; 2021 Sep; 10(9):. PubMed ID: 34571996
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial approach to increase efficacy of Cetuximab, Panitumumab and Trastuzumab by dianthin conjugation and co-application of SO1861.
Gilabert-Oriol R; Weng A; Trautner A; Weise C; Schmid D; Bhargava C; Niesler N; Wookey PJ; Fuchs H; Thakur M
Biochem Pharmacol; 2015 Oct; 97(3):247-55. PubMed ID: 26253687
[TBL] [Abstract][Full Text] [Related]
4. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861.
Panjideh H; Niesler N; Weng A; Fuchs H
Toxins (Basel); 2022 Jul; 14(7):. PubMed ID: 35878216
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD30 immunotoxins with native and recombinant dianthin 30.
Bolognesi A; Tazzari PL; Legname G; Olivieri F; Modena D; Conte R; Stirpe F
Cancer Immunol Immunother; 1995 Feb; 40(2):109-14. PubMed ID: 7882380
[TBL] [Abstract][Full Text] [Related]
6. Mutational Analysis of RIP Type I Dianthin-30 Suggests a Role for Arg24 in Endocytosis.
Schlaak L; Weise C; Kuropka B; Weng A
Toxins (Basel); 2024 May; 16(5):. PubMed ID: 38787071
[TBL] [Abstract][Full Text] [Related]
7. Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.
Pirie CM; Hackel BJ; Rosenblum MG; Wittrup KD
J Biol Chem; 2011 Feb; 286(6):4165-72. PubMed ID: 21138845
[TBL] [Abstract][Full Text] [Related]
8. Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas.
Ostrovskaya A; Hick C; Hutchinson DS; Stringer BW; Wookey PJ; Wootten D; Sexton PM; Furness SGB
BMC Cancer; 2019 Feb; 19(1):157. PubMed ID: 30777055
[TBL] [Abstract][Full Text] [Related]
9. Conjugating MMAE to a novel anti-HER2 antibody for selective targeted delivery.
Li L; Xu MZ; Wang L; Jiang J; Dong LH; Chen F; Dong K; Song HF
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12929-12937. PubMed ID: 33378043
[TBL] [Abstract][Full Text] [Related]
10. Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.
Pagliaro LC; Liu B; Munker R; Andreeff M; Freireich EJ; Scheinberg DA; Rosenblum MG
Clin Cancer Res; 1998 Aug; 4(8):1971-6. PubMed ID: 9717827
[TBL] [Abstract][Full Text] [Related]
11. Genetic engineering and characterisation of chlorotoxin-fused gelonin for enhanced glioblastoma therapy.
Park T; Min KA; Cheong H; Moon C; Shin MC
J Drug Target; 2019 Nov; 27(9):950-958. PubMed ID: 30156929
[TBL] [Abstract][Full Text] [Related]
12. The expression of calcitonin receptor detected in malignant cells of the brain tumour glioblastoma multiforme and functional properties in the cell line A172.
Wookey PJ; McLean CA; Hwang P; Furness SG; Nguyen S; Kourakis A; Hare DL; Rosenfeld JV
Histopathology; 2012 May; 60(6):895-910. PubMed ID: 22335784
[TBL] [Abstract][Full Text] [Related]
13. Transferrin toxin but not transferrin receptor immunotoxin is influenced by free transferrin and iron saturation.
Gosselaar PH; van-Dijk AJ; de-Gast GC; Polito L; Bolognesi A; Vooijs WC; Verheul AF; Krouwer HG; Marx JJ
Eur J Clin Invest; 2002 Mar; 32 Suppl 1():61-9. PubMed ID: 11886434
[TBL] [Abstract][Full Text] [Related]
14. cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity.
Francisco JA; Cerveny CG; Meyer DL; Mixan BJ; Klussman K; Chace DF; Rejniak SX; Gordon KA; DeBlanc R; Toki BE; Law CL; Doronina SO; Siegall CB; Senter PD; Wahl AF
Blood; 2003 Aug; 102(4):1458-65. PubMed ID: 12714494
[TBL] [Abstract][Full Text] [Related]
15. Targeted dianthin is a powerful toxin to treat pancreatic carcinoma when applied in combination with the glycosylated triterpene SO1861.
Bhargava C; Dürkop H; Zhao X; Weng A; Melzig MF; Fuchs H
Mol Oncol; 2017 Nov; 11(11):1527-1543. PubMed ID: 28755527
[TBL] [Abstract][Full Text] [Related]
16. Fusion of gelonin and anti-insulin-like growth factor-1 receptor (IGF-1R) affibody for enhanced brain cancer therapy.
Ham S; Min KA; Yang JW; Shin MC
Arch Pharm Res; 2017 Sep; 40(9):1094-1104. PubMed ID: 28900896
[TBL] [Abstract][Full Text] [Related]
17. A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2.
Mujoo K; Reisfeld RA; Cheung L; Rosenblum MG
Cancer Immunol Immunother; 1991; 34(3):198-204. PubMed ID: 1756537
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of antitissue factor antibody-MMAE conjugate in human pancreatic tumor xenografts.
Koga Y; Manabe S; Aihara Y; Sato R; Tsumura R; Iwafuji H; Furuya F; Fuchigami H; Fujiwara Y; Hisada Y; Yamamoto Y; Yasunaga M; Matsumura Y
Int J Cancer; 2015 Sep; 137(6):1457-66. PubMed ID: 25704403
[TBL] [Abstract][Full Text] [Related]
19. Purification of immunotoxins containing the ribosome-inactivating proteins gelonin and momordin using high performance liquid immunoaffinity chromatography compared with blue sepharose CL-6B affinity chromatography.
Cumber AJ; Henry RV; Parnell GD; Wawrzynczak EJ
J Immunol Methods; 1990 Dec; 135(1-2):15-24. PubMed ID: 2273254
[TBL] [Abstract][Full Text] [Related]
20. Targeting of type 1 ribosome-inactivating proteins to CD30+ or CD25+ hematologic neoplasias by bispecific antibodies.
Sforzini S; Bolognesi A; Meazza R; Marciano S; Tazzari PL; Stein H; Stirpe F; Ferrini S
J Hematother; 1995 Oct; 4(5):429-32. PubMed ID: 8581380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
